Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather E Olson

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Annals of Neurology|December 16, 2020
Characterization of the GABRB2-Associated Neurodevelopmental DisordersChristelle M El Achkar, Merle Harrer, Lacey Smith, et al.
Epilepsy Research|September 26, 2023
The development, content and response process validation of a caregiver-reported severity measure for CDKL5 deficiency disorderSonja I Ziniel, Alexandra Mackie, Jacinta Saldaris, et al.
Epilepsia|July 18, 2019
CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and developmentScott T Demarest, Heather E Olson, Angela Moss, et al.
Journal of Neurodevelopmental Disorders|March 4, 2023
Comparison of evoked potentials across four related developmental encephalopathiesJoni N Saby, Sarika U Peters, Timothy A Benke, et al.
Neurology|August 21, 2015
SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizuresKatherine B Howell, Jacinta M McMahon, Gemma L Carvill, et al.
Brain Communications|August 17, 2022
Electrophysiological biomarkers of brain function in CDKL5 deficiency disorderJoni N Saby, Patrick J Mulcahey, Alexis E Zavez, et al.
Annals of Neurology|January 31, 2017
Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppressionHeather E Olson, McKenna Kelly, Christopher M LaCoursiere, et al.
Brain Sciences|August 9, 2018
Clinical and Functional Characterization of the Recurrent TUBA1A p.(Arg2His) MutationJennifer F Gardner, Thomas D Cushion, Georgios Niotakis, et al.
Journal of Neurodevelopmental Disorders|September 17, 2021
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorderHeather E Olson, Carolyn I Daniels, Isabel Haviland, et al.
Epilepsia|April 28, 2023
Epileptic spasms in CDKL5 deficiency disorder: Delayed treatment and poor response to first-line therapiesHeather E Olson, Scott Demarest, Elia Pestana-Knight, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Annals of Neurology|December 16, 2020
Characterization of the GABRB2-Associated Neurodevelopmental DisordersChristelle M El Achkar, Merle Harrer, Lacey Smith, et al.
Epilepsy Research|September 26, 2023
The development, content and response process validation of a caregiver-reported severity measure for CDKL5 deficiency disorderSonja I Ziniel, Alexandra Mackie, Jacinta Saldaris, et al.
Epilepsia|July 18, 2019
CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and developmentScott T Demarest, Heather E Olson, Angela Moss, et al.
Journal of Neurodevelopmental Disorders|March 4, 2023
Comparison of evoked potentials across four related developmental encephalopathiesJoni N Saby, Sarika U Peters, Timothy A Benke, et al.
Neurology|August 21, 2015
SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizuresKatherine B Howell, Jacinta M McMahon, Gemma L Carvill, et al.
Brain Communications|August 17, 2022
Electrophysiological biomarkers of brain function in CDKL5 deficiency disorderJoni N Saby, Patrick J Mulcahey, Alexis E Zavez, et al.
Annals of Neurology|January 31, 2017
Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppressionHeather E Olson, McKenna Kelly, Christopher M LaCoursiere, et al.
Brain Sciences|August 9, 2018
Clinical and Functional Characterization of the Recurrent TUBA1A p.(Arg2His) MutationJennifer F Gardner, Thomas D Cushion, Georgios Niotakis, et al.
Journal of Neurodevelopmental Disorders|September 17, 2021
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorderHeather E Olson, Carolyn I Daniels, Isabel Haviland, et al.
Epilepsia|April 28, 2023
Epileptic spasms in CDKL5 deficiency disorder: Delayed treatment and poor response to first-line therapiesHeather E Olson, Scott Demarest, Elia Pestana-Knight, et al.
Pageof 5